ctrl K

Price Alert

Terns Pharmaceuticals Inc... (TERN)

NASDAQ: TERN · Real-Time Price · USD

7.07

0.30 (4.43%)

At close: Aug 15, 2025, 3:59 PM

7.06

-0.07%

After-hours: Aug 15, 2025, 05:20 PM EDT

Terns Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	161.44M	79.93M	143.24M	47.7M
Short-Term Investments	196.72M	183.51M	139.88M	118.28M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	350K	56K	37K	94K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	3.94M	3.99M	2.07M	948K
Total Current Assets	362.11M	267.43M	285.19M	166.93M
Property-Plant & Equipment	1.47M	1.03M	1.8M	1.05M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.82M	1.08M	1.84M	1.14M
Total Assets	363.93M	268.52M	287.03M	168.07M
Account Payables	2.15M	2.52M	1.65M	2.13M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	428K	n/a	661K	n/a
Other Current Liabilities	8.37M	5.96M	3.37M	358K
Total Current Liabilities	15.65M	11.94M	8.47M	6.82M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.49M	1.21M	1.07M	947K
Total Long-Term Liabilities	2.41M	1.21M	1.61M	947K
Total Liabilities	18.06M	13.15M	10.08M	7.77M
Total Debt	1.35M	603K	1.21M	n/a
Common Stock	9K	6K	5K	3K
Retained Earnings	-421.48M	-332.63M	-242.42M	-182.07M
Comprehensive Income	-279K	-19K	-822K	-338K
Shareholders Equity	345.87M	255.37M	276.94M	160.3M
Total Investments	196.72M	183.51M	139.88M	118.28M